For: | Yim C, Mansell K, Hussein N, Arnason T. Current cancer therapies and their influence on glucose control. World J Diabetes 2021; 12(7): 1010-1025 [PMID: 34326951 DOI: 10.4239/wjd.v12.i7.1010] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v12/i7/1010.htm |
Number | Citing Articles |
1 |
Elizabeth R. Stirling, Steven M. Bronson, Jessica D. Mackert, Katherine L. Cook, Pierre L. Triozzi, David R. Soto-Pantoja. Metabolic Implications of Immune Checkpoint Proteins in Cancer. Cells 2022; 11(1): 179 doi: 10.3390/cells11010179
|
2 |
Angela Zanfardino, Patrizia Bruzzi, Michela Trada, Novella Rapini, Emanuela Laudani, Gianluca Tornese, Federica Ortolani, Gianluca Piccolo, Lorena Matonti, Maria Alessandra Saltarelli, Tiziana Timpanaro, Giuseppe D’Annunzio, Barbara Predieri, Francesca Rossi, Rossella Mura, Veronica Barat, Arcangelo Prete, Riccardo Schiaffini, Stefano Zucchini. The real-life management of glucose homeostasis abnormalities in pediatric onco-hematological diseases: data from a national survey. Pediatric Hematology and Oncology 2024; 41(3): 198 doi: 10.1080/08880018.2023.2295454
|
3 |
Terra Arnason, Kerry Mansell. The Juncture of Diabetes, Cancer, and Observational Population-based Studies: Novel Insights From Canadian Provincial Health Records. Canadian Journal of Diabetes 2024; 48(3): 145 doi: 10.1016/j.jcjd.2024.02.002
|
4 |
Qiaoling Yang, Chuping Chen, Jianmin Ran. Capecitabine-induced severe diabetes and hypokalemia: a case report. Journal of Medical Case Reports 2022; 16(1) doi: 10.1186/s13256-022-03392-w
|
5 |
Tomasz Klupa, Leszek Czupryniak, Grzegorz Dzida, Piotr Fichna, Przemyslawa Jarosz-Chobot, Janusz Gumprecht, Malgorzata Mysliwiec, Agnieszka Szadkowska, Dorota Bomba-Opon, Krzysztof Czajkowski, Maciej T. Malecki, Dorota A. Zozulinska-Ziolkiewicz. Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease. Diabetes Therapy 2023; 14(8): 1241 doi: 10.1007/s13300-023-01431-3
|
6 |
Rashed Harun, Rucha Sane, Kenta Yoshida, Dhruvitkumar S. Sutaria, Jin Y. Jin, James Lu. Risk Factors of Hyperglycemia After Treatment With the AKT Inhibitor Ipatasertib in the Prostate Cancer Setting: A Machine Learning–Based Investigation. JCO Clinical Cancer Informatics 2023; (7) doi: 10.1200/CCI.22.00168
|
7 |
Hongyu Wang, Xiao She, Qiongdong Xu, Xingyu Zhou, Qinchao Tang, Huakun Wei, Tianjing Huang, Feixin Liang. Linagliptin's impact on lymphatic barrier and lymphangiogenesis in oral cancer with high glucose. Oral Diseases 2024; doi: 10.1111/odi.14893
|
8 |
Róbert János Bánhegyi, Blanka Veréb, Andrea Gazdag, Beatrix Rácz, Róbert Wagner, Norbert Fülöp, Béla Pikó. Onkodiabetológia III.. Orvosi Hetilap 2022; 163(41): 1614 doi: 10.1556/650.2022.32635
|
9 |
Christian Jenssen, Cristine Pietsch. Stationäre Patienten mit der Nebendiagnose Diabetes mellitus: klinische Relevanz. Die Diabetologie 2022; 18(4): 379 doi: 10.1007/s11428-022-00897-2
|
10 |
Maria V. Deligiorgi, Dimitrios T. Trafalis. A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors. International Journal of Molecular Sciences 2023; 24(8): 7630 doi: 10.3390/ijms24087630
|